SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-22-081609
Filing Date
2022-03-22
Accepted
2022-03-22 16:07:29
Documents
7

Document Format Files

Seq Description Document Type Size
1 POS AM d335824dposam.htm POS AM 408796
2 EX-5.1 d335824dex51.htm EX-5.1 26146
3 EX-23.2 d335824dex232.htm EX-23.2 1255
4 GRAPHIC g335824g02v00.jpg GRAPHIC 33632
5 GRAPHIC g335824g0319044606484.jpg GRAPHIC 3252
6 GRAPHIC g335824g0319044606953.jpg GRAPHIC 1414
7 GRAPHIC g335824g17x00.jpg GRAPHIC 43888
  Complete submission text file 0001193125-22-081609.txt   543100
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-255833 | Film No.: 22759585
SIC: 2834 Pharmaceutical Preparations